Furthermore, emerging biomarkers such as neutrophil gelatinase–associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) have demonstrated greater sensitivity in the early detection of AKI, often rising before elevations in traditional markers like creatinine and urea [53]. The gene discussed is LCN2; the disease is acute kidney injury.